Placebo for ABI-H0731

DRUG2 trials

Sponsors

Assembly Biosciences

Conditions

Chronic Hepatitis B

Phase 1

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

CompletedNCT02908191

Assembly BiosciencesChronic Hepatitis B

Start: 2016-11-30End: 2018-06-12Updated: 2019-04-04

Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

CompletedNCT03109730

Assembly BiosciencesChronic Hepatitis B

Start: 2017-06-15End: 2018-06-12Updated: 2018-07-06

Related Papers

Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial.

2019-11-0982 citations